Sonic completes acquisition of GLP
Tuesday, 02 September, 2008
Sonic Healthcare [ASX: SHL] has completed the acquisition of the German GLP Medical Group.
The deal, first announced in June, sees Sonic taking control of a company which employs some 250 staff, and an expected EBITDA of around $3.5 million for the 2008/09 financial year.
Sonic and GLP have a history of collaboration due to the proximity of the GLP labs to the Sonic-operated Bioscientia Healthcare and the Schottdorf group laboratories, all of which are located in Hamburg.
Multiple myeloma treatment reprograms patients' own immune cells
An Australian and Victorian Government funding agreement has allowed eligible Australians with...
Could 'fusion proteins' reduce errors in a promising gene-editing tool?
Gene-editing tool CRISPR-Cas9 is used, among many things, to engineer new cancer immunotherapies....
Cancer research and clinical trials at the core of new centre
The Australian Cancer Research Foundation Centre for Dynamic Immuno-Oncology (CDIO) has been...
